Treatment of refractory pyoderma gangrenosum with infliximab in a 17-month-old boy
Bobbitt, S.A.; Klaus, E.M.; Stringer, E.; Chowdhury, D.; Finlayson, L.
Dermatology Online Journal 22(4)
2016
ISSN/ISBN: 1087-2108 PMID: 27617462 Document Number: 686599
This report details the case of a 17-month old boy with refractory multifocal pyoderma gangrenosum responsive to anti-TNF therapy.
Document emailed within 1 workday
Related Documents
Chan, J.L.; Graves, M.S.; Cockerell, C.J.; Pandya, A.G. 2010: Rapid improvement of pyoderma gangrenosum after treatment with infliximab Journal of Drugs in Dermatology: Jdd 9(6): 702-704McGowan, J.W.; Johnson, C.A.; Lynn, A. 2004: Treatment of pyoderma gangrenosum with etanercept Journal of Drugs in Dermatology: Jdd 3(4): 441-444
Azizan, N.Z.; Gangaram, H.B.; Hussein, S.H. 2008: A novel therapy for the treatment of pyoderma gangrenosum Medical Journal of Malaysia 63(1): 51-54
Handler, M.Z.; Hamilton, H.; Aires, D. 2011: Treatment of peristomal pyoderma gangrenosum with topical crushed dapsone Journal of Drugs in Dermatology: Jdd 10(9): 1059-1061
Nordstrom, D. 1995: Intravenous cyclophosphamide pulses in the treatment of pyoderma gangrenosum associated with rheumatoid arthritis Journal of Rheumatology 22(5): 1000-1001
Din, R.S.; Tsiaras, W.G.; Li, D.G.; Mostaghimi, A. 2018: Efficacy of Systemic Dapsone Treatment for Pyoderma Gangrenosum: A Retrospective Review Journal of Drugs in Dermatology: Jdd 17(10): 1058-1060
Neiderer, K.; Martin, B.; Hoffman, S.; Jolley, D.; Dancho, J. 2012: A mechanically powered negative pressure device used in conjunction with a bioengineered cell-based product for the treatment of pyoderma gangrenosum: a case report Ostomy/Wound Management 58(9): 44-48
Neill, B.C..; Seger, E.W..; Hooton, T.A..; Bailey, G.; Rajpara, A.; Stoecker, W.V.. 2019: The 5 P's of Pyoderma Gangrenosum Journal of Drugs in Dermatology: Jdd 18(12): 1282-1283
Salvarani, C.; Cantini, F.; Niccoli, L.; Catanoso, M.Grazia.; Macchioni, P.; Pulsatelli, L.; Padula, A.; Olivieri, I.; Boiardi, L. 2003: Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study Journal of Rheumatology 30(4): 760-763
Cobo-Ibáñez, T.; Muñoz-Fernández, S.; Hidalgo-Barrero, V.; Martín-Mola, E. 2006: Medium-long term treatment with infliximab and methotrexate in posterior and/or chronic uveitis refractory to conventional treatment Medicina Clinica 126(1): 34-35
Leger, M.; Newlove, T.; Chu, J.; Meehan, S.; Stein, J. 2011: Pustular pyoderma gangrenosum Dermatology Online Journal 17(10): 17
Feuerman, E.; Potruch-Eisenkraft, S. 1971: The problem of pyoderma gangrenosum Harefuah 80(5): 251-254
El Fékih, N.; Kerkeni, N.; Kharfi, M.; Baccouche, D.; Zéglaoui, F.; Fazaa, B.; Kamoun Mohamed, R. 2010: Pyoderma gangrenosum: 6 cases Revue Medicale de Liege 65(9): 506-509
El-Kehdy, J.; Haneke, E.; Karam, P.G. 2013: Pyoderma gangrenosum: a misdiagnosis Journal of Drugs in Dermatology: Jdd 12(2): 228-230
Allegue Rodriguez, F.; Marques Huberti, A.; Freire Murgueytio, P.; Ledo Pozueta, A. 1988: Peristomal pyoderma gangrenosum Annales de Dermatologie et de Venereologie 115(4): 485
Labarca, Cán.; Massardo, L.; García, P.I.; Jacobelli, S. 2003: Effectiveness of infliximab in patients with inflammatory arthritis refractory to conventional treatment Revista Medica de Chile 131(10): 1157-1164
Rubisz-Brzezinska, J.; Seferowicz, E.; Dabrowski, Z. 1971: Pyoderma gangrenosum (dermatitis ulcerosa) Przeglad Dermatologiczny 58(3): 317-323
Pawar, G.P.; Satija, V.K.; Pawar, B. 1987: Pyoderma gangrenosum in ulcerative colitis Journal of the Association of Physicians of India 35(6): 448-450
López de Maturana, D.; Amaro, P.; Aranibar, L.; Segovia, L. 2001: Pyoderma gangrenosum: report of 11 cases Revista Medica de Chile 129(9): 1044-1050
Galliez, M.; Mangin, M.; Claudy, A.; Hugonnier, P.; Relave, M.H.; Auboyer, C. 1990: Post-surgical pyoderma gangrenosum Presse Medicale 19(28): 1326